XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies - Subsequent Events (Details)
Apr. 26, 2024
Apr. 11, 2024
USD ($)
Feb. 13, 2020
USD ($)
May 31, 2024
USD ($)
Jan. 31, 2024
USD ($)
Share repurchase program authorized amount         $ 150,000,000
Subsequent Events          
Share repurchase program authorized amount       $ 35,000,000  
Hikma Pharmaceuticals USA Inc. | Subsequent Events          
Period for launching the product prior to loss of exclusivity for each product or earlier 30 days        
Percentage of AG agreement profit sharing 80.00%        
AG Agreement initial term 5 years        
AG Agreement renewal term 1 year        
AG Agreement period of termination 1 year        
2026 Convertible Notes          
Aggregate principal amount of notes repurchased     $ 117,400,000    
Interest rate (as a percent)     2.625%    
Conversion rate     34.2618    
2026 Convertible Notes | Subsequent Events          
Aggregate principal amount of notes repurchased   $ 26,350,000      
Interest rate (as a percent)   2.625%      
Debt Instrument, Redemption Price, Percentage   100.00%      
Debt Instrument, Convertible, Redemption Price   $ 1,008.68      
Conversion rate   36.7815